Hapvida clarifies contract adjustments for 947,000 beneficiaries remain undefined

Brazilian healthcare provider Hapvida stated that premium adjustments for nearly one million lives are currently undetermined and will be applied non-uniformly. The lack of specific pricing details creates uncertainty regarding the company's revenue trajectory and potential impact on subscriber retention.